Whitepapers

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Antibody Drug Conjugates Re-emergence of an old modality for targeted therapies
Introduction Antibody drug conjugates (ADCs) are a class of targeted drugs composed of a cytotoxic payload linked to an antibody that targets a cancer cell, designed...
Quality management paradigm shift: Risk-centric practices take center stage
Introduction The pharmaceutical industry is witnessing a paradigm shift in quality management (QM) as risk-based approaches become integral to ensuring compliance and efficiency. With the...
Protein therapeutics to amp-up outsourcing in animal health
Introduction The animal health industry is experiencing rapid growth, driven by increasing pet ownership and rising demand for advanced veterinary treatments. Protein therapeutics, particularly monoclonal...
CROs at the High Table of Drug Discovery
Introduction Contract Research Organizations (CROs) have evolved from simple service providers to key strategic partners in drug discovery. Initially, pharmaceutical companies outsourced limited tasks to...
Inside the growing precision therapy market and the crucial role of pDNA manufacturing
Introduction The precision therapy market is rapidly expanding, driven by breakthroughs in mRNA-based treatments, viral vector-based gene therapies, and gene-modified cell therapies. A crucial component...
Antibody Drug Conjugates: Re-emergence of an old modality for targeted therapies
Introduction Antibody drug conjugates (ADCs) are a class of targeted drugs composed of a cytotoxic payload linked to an antibody that targets a cancer cell, designed...

To view or email, Please share your details view

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details